Ben R. Taylor

Insider Reports History

Entity
Individual
Location
44 Wall Street, 12 Th Floor, New York, NY
Signature
/s/ Kyle Nelson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ben R. Taylor:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Class A Common Stock 842K $4.29M $5.10 Apr 1, 2025 Direct
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 290K Apr 1, 2025 Direct

Insider Reports Filed by Ben R. Taylor

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Apr 1, 2025 1 -$135K 4 Apr 3, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Mar 17, 2025 1 -$48.3K 4 Mar 19, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 18, 2025 1 -$116K 4 Feb 20, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 3, 2025 4 -$47.4K 4 Feb 5, 2025 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Dec 19, 2024 2 $0 4 Dec 20, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Dec 16, 2024 2 -$144K 4 Dec 18, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Nov 20, 2024 0 $0 3 Dec 2, 2024 Chief Financial Officer